No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
ESEA Euroseas
- 38.965
- +0.275+0.71%
Trading Jul 23 11:21 ET
270.96MMarket Cap2.55P/E (TTM)
38.965High38.360Low7.50KVolume38.360Open38.690Pre Close289.87KTurnover0.27%Turnover Ratio2.36P/E (Static)6.95MShares42.45852wk High0.96P/B107.33MFloat Cap19.63152wk Low2.10Dividend TTM2.75MShs Float1058.093Historical High5.39%Div YieldTTM1.56%Amplitude1.028Historical Low38.674Avg Price1Lot Size
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Euroseas Ltd. Shareholders Approve Key Resolutions
Maxim Group Maintains Euroseas(ESEA.US) With Buy Rating, Maintains Target Price $55
Maxim Group Maintains Euroseas(ESEA.US) With Buy Rating, Announces Target Price $55
Buy Recommendation for Euroseas on Robust Financial Outlook and Market Position
Noble Financial Maintains Euroseas(ESEA.US) With Buy Rating, Raises Target Price to $55
Ship operator Euroseas (ESEA.US) signed a two-year ship charter contract and will contribute $6.4 million in profit.
Shipping company euroseas announced on Tuesday that it has signed a regular lease contract for a feeder container ship with an unnamed "top liner company".
Comments
2
Gainers:
• $SpringWorks Therapeutics(SWTX.US$ +19.2% (Nirogacestat Achieved Primary and All Key Secondary Endpoints in Phase3DeFi Trial )
• $Roivant Sciences(ROIV.US$ +7.1% (FDA has approved VTAMA (tapinarof) cream)
• $Ocugen(OCGN.US$ +5.9% (announces that it is diversifying its innovative pipeline by introducing a Phase 3 cell therapy platform technology called Ne?Cart)
• $Skyline(SKY.US$ +4.4% (In reaction to earnings）
• $NetEase(NTES.US$ +4.1% (In...
• $SpringWorks Therapeutics(SWTX.US$ +19.2% (Nirogacestat Achieved Primary and All Key Secondary Endpoints in Phase3DeFi Trial )
• $Roivant Sciences(ROIV.US$ +7.1% (FDA has approved VTAMA (tapinarof) cream)
• $Ocugen(OCGN.US$ +5.9% (announces that it is diversifying its innovative pipeline by introducing a Phase 3 cell therapy platform technology called Ne?Cart)
• $Skyline(SKY.US$ +4.4% (In reaction to earnings）
• $NetEase(NTES.US$ +4.1% (In...
11
Gainers:
• $Microvast(MVST.US$ +14.6% (In reaction to earnings)
• $Sea(SE.US$ +11.3% (Q1 adjusted loss expands, revenue jumps)
• $JD.com(JD.US$ +9.1% (beating top-line and bottom-line estimates for its latest quarter)
• $Coinbase(COIN.US$ +6.3% (announces it is "slowing hiring so we can reprioritize our hiring needs against our highest-priority business goals")
• $Heliogen(HLGN.US$ +5%(to restate Full Year 2021 Financials)
• $Take-Two Interactive Software(TTWO.US$ +4.9% (de...
• $Microvast(MVST.US$ +14.6% (In reaction to earnings)
• $Sea(SE.US$ +11.3% (Q1 adjusted loss expands, revenue jumps)
• $JD.com(JD.US$ +9.1% (beating top-line and bottom-line estimates for its latest quarter)
• $Coinbase(COIN.US$ +6.3% (announces it is "slowing hiring so we can reprioritize our hiring needs against our highest-priority business goals")
• $Heliogen(HLGN.US$ +5%(to restate Full Year 2021 Financials)
• $Take-Two Interactive Software(TTWO.US$ +4.9% (de...
21
2
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
I Am 102927471 :